BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34715889)

  • 1. RaDiCo, the French national research program on rare disease cohorts.
    Amselem S; Gueguen S; Weinbach J; Clement A; Landais P;
    Orphanet J Rare Dis; 2021 Oct; 16(1):454. PubMed ID: 34715889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Domain-Specific Common Data Elements for Rare Disease Registration: Conceptual Approach of a European Joint Initiative Toward Semantic Interoperability in Rare Disease Research.
    Abaza H; Kadioglu D; Martin S; Papadopoulou A; Dos Santos Vieira B; Schaefer F; Storf H
    JMIR Med Inform; 2022 May; 10(5):e32158. PubMed ID: 35594066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sustainable solution for the activities of the European network for surveillance of congenital anomalies: EUROCAT as part of the EU Platform on Rare Diseases Registration.
    Kinsner-Ovaskainen A; Lanzoni M; Garne E; Loane M; Morris J; Neville A; Nicholl C; Rankin J; Rissmann A; Tucker D; Martin S
    Eur J Med Genet; 2018 Sep; 61(9):513-517. PubMed ID: 29597096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders.
    Parker S
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv9-14. PubMed ID: 25165190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model for the European platform for rare disease registries.
    Vittozzi L; Gainotti S; Mollo E; Donati C; Taruscio D
    Public Health Genomics; 2013; 16(6):299-304. PubMed ID: 24503590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A methodology for a minimum data set for rare diseases to support national centers of excellence for healthcare and research.
    Choquet R; Maaroufi M; de Carrara A; Messiaen C; Luigi E; Landais P
    J Am Med Inform Assoc; 2015 Jan; 22(1):76-85. PubMed ID: 25038198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare Diseases in Europe: from a Wide to a Local Perspective.
    Baldovino S; Moliner AM; Taruscio D; Daina E; Roccatello D
    Isr Med Assoc J; 2016 Jun; 18(6):359-63. PubMed ID: 27468531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of patients' cohorts in the French National rare disease registry.
    Pichon T; Messiaen C; Soussand L; Angin C; Sandrin A; Elarouci N; Jannot AS;
    Orphanet J Rare Dis; 2023 Jul; 18(1):176. PubMed ID: 37400917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unmet needs in countries participating in the undiagnosed diseases network international: an international survey considering national health care and economic indicators.
    Sciascia S; Roccatello D; Salvatore M; Carta C; Cellai LL; Ferrari G; Lumaka A; Groft S; Alanay Y; Azam M; Baynam G; Cederroth H; Cutiongco-de la Paz EM; Dissanayake VHW; Giugliani R; Gonzaga-Jauregui C; Hettiarachchi D; Kvlividze O; Landoure G; Makay P; Melegh B; Ozbek U; Puri RD; Romero VI; Scaria V; Jamuar SS; Shotelersuk V; Gahl WA; Wiafe SA; Bodamer O; Posada M; Taruscio D
    Front Public Health; 2023; 11():1248260. PubMed ID: 37822540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Tuscany Regional Network for rare diseases: from European Reference Networks' experience to registry based organisation and management model for rare diseases.
    Pieroni F; Marrucci S; Di Pietro L; Berni C; Scaletti C
    Orphanet J Rare Dis; 2023 Oct; 18(1):324. PubMed ID: 37833795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EuRRECa Project as a Model for Data Access and Governance Policies for Rare Disease Registries That Collect Clinical Outcomes.
    Ali SR; Bryce J; Tan LE; Hiort O; Pereira AM; van den Akker ELT; Appelman-Dijkstra NM; Bertherat J; Cools M; Dekkers OM; Kodra Y; Persani L; Smyth A; Smythe C; Taruscio D; Ahmed SF
    Int J Environ Res Public Health; 2020 Nov; 17(23):. PubMed ID: 33255540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RD-Connect, NeurOmics and EURenOmics: collaborative European initiative for rare diseases.
    Lochmüller H; Badowska DM; Thompson R; Knoers NV; Aartsma-Rus A; Gut I; Wood L; Harmuth T; Durudas A; Graessner H; Schaefer F; Riess O; ; ;
    Eur J Hum Genet; 2018 Jun; 26(6):778-785. PubMed ID: 29487416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study.
    Linertová R; Serrano-Aguilar P; Posada-de-la-Paz M; Hens-Pérez M; Kanavos P; Taruscio D; Schieppati A; Stefanov R; Péntek M; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G; Worbes-Cerezo M; Sefton M; López-Bastida J;
    Health Policy; 2012 Nov; 108(1):19-26. PubMed ID: 22947412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic similarity-based approach for variant prioritization for unsolved rare disease: a preliminary methodological report.
    Lagorce D; Lebreton E; Matalonga L; Hongnat O; Chahdil M; Piscia D; Paramonov I; Ellwanger K; Köhler S; Robinson P; Graessner H; Beltran S; Lucano C; Hanauer M; Rath A
    Eur J Hum Genet; 2024 Feb; 32(2):182-189. PubMed ID: 37926714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare diseases in the year 2019 - the Czech and international context.
    Macek M
    Cas Lek Cesk; 2019; 158(1):33-37. PubMed ID: 31046390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Healthcare networks for people with rare diseases: integrating data and expertise].
    Graessner H; Storf H; Schaefer F
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Nov; 65(11):1164-1169. PubMed ID: 36167994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How the EUCERD Joint Action supported initiatives on Rare Diseases.
    Lynn S; Hedley V; Atalaia A; Evangelista T; Bushby K;
    Eur J Med Genet; 2017 Mar; 60(3):185-189. PubMed ID: 28087401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An innovative technological infrastructure for managing SARS-CoV-2 data across different cohorts in compliance with General Data Protection Regulation.
    Dellacasa C; Ortali M; Rossi E; Abu Attieh H; Osmo T; Puskaric M; Rinaldi E; Prasser F; Stellmach C; Cataudella S; Agarwal B; Mata Naranjo J; Scipione G
    Digit Health; 2024; 10():20552076241248922. PubMed ID: 38766364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.